Literature DB >> 24839974

Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?

Roland E Schmieder1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24839974     DOI： 10.1038/nrcardio.2014.70

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Authors:  Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2013-09       Impact factor: 4.844

2.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

3.  Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Authors: 
Journal:  Hypertension       Date:  2011-03-14       Impact factor: 10.190

4.  Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.

Authors:  Sripal Bangalore; Rana Fayyad; Rachel Laskey; David A Demicco; Prakash Deedwania; John B Kostis; Franz H Messerli
Journal:  Am J Med       Date:  2013-11-07       Impact factor: 4.965

5.  Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.

Authors:  Christina S Oxlund; Jan E Henriksen; Lise Tarnow; Karoline Schousboe; Jeppe Gram; Ib A Jacobsen
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

6.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

7.  A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.

Authors:  Michael A Weber; Henry Black; George Bakris; Henry Krum; Stuart Linas; Robert Weiss; Jennifer V Linseman; Brian L Wiens; Marshelle S Warren; Lars H Lindholm
Journal:  Lancet       Date:  2009-09-11       Impact factor: 79.321

8.  Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.

Authors:  Felix Mahfoud; Christian Ukena; Roland E Schmieder; Bodo Cremers; Lars C Rump; Oliver Vonend; Joachim Weil; Martin Schmidt; Uta C Hoppe; Thomas Zeller; Axel Bauer; Christian Ott; Erwin Blessing; Paul A Sobotka; Henry Krum; Markus Schlaich; Murray Esler; Michael Böhm
Journal:  Circulation       Date:  2013-06-18       Impact factor: 29.690

9.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245
  9 in total
  9 in total

1.  Ethnicity and sympathetic tone: predictors of the blood pressure response to renal denervation?

Authors:  Yutang Wang
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

2.  Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

Authors:  Roland E Schmieder
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

Review 3.  Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.

Authors:  Alexandre Persu; Fadl Elmula M Fadl Elmula; Yu Jin; Ingrid Os; Sverre E Kjeldsen; Jan A Staessen
Journal:  Eur Cardiol       Date:  2014-12

Review 4.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

5.  Renal denervation for severe hypertension in a small child with Turner syndrome: miniaturisation of the procedure and results.

Authors:  Alice Bonanni; Francesco Pasetti; Gian Marco Ghiggeri; Carlo Gandolfo
Journal:  BMJ Case Rep       Date:  2015-03-10

Review 6.  Where and when device therapy may be useful in the management of drug-resistant hypertension.

Authors:  Herbert D Aronow; Jun Li; Sahil A Parikh
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

Review 7.  Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Anne C Larstorp; Sverre E Kjeldsen; Alexandre Persu; Yu Jin; Jan A Staessen
Journal:  Front Physiol       Date:  2015-02-09       Impact factor: 4.566

Review 8.  Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.

Authors:  Michael J McArdle; Emil M deGoma; Debbie L Cohen; Raymond R Townsend; Robert L Wilensky; Jay Giri
Journal:  J Am Heart Assoc       Date:  2015-03-23       Impact factor: 5.501

9.  Acupuncture Attenuates Renal Sympathetic Activity and Blood Pressure via Beta-Adrenergic Receptors in Spontaneously Hypertensive Rats.

Authors:  Jing-Wen Yang; Yang Ye; Xue-Rui Wang; Fang Li; Ling-Yong Xiao; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Neural Plast       Date:  2017-02-08       Impact factor: 3.599
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.